Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.300
-0.064-1.47%
Volume:16.35M
Turnover:70.38M
Market Cap:27.02B
PE:5.72
High:4.380
Open:4.365
Low:4.275
Close:4.364
52wk High:6.336
52wk Low:4.211
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:1.42
T/O Rate:0.26%
Dividend:0.22
Dividend Rate:5.07%
EPS(LYR):0.752
ROE:8.32%
ROA:2.64%
PB:0.44
PE(LYR):5.72
PS:0.08

Loading ...

CHINARES PHARMA Subsidiary Successfully Issues 1.8 Billion Yuan Corporate Bonds

Stock News
·
Mar 27

China Resources Pharmaceutical affiliate CR Pharmaceutical Commercial issues 2026 corporate bonds; RMB1.8 billion tranche sets 1.70% coupon

Reuters
·
Mar 27

CLSA Maintains Outperform Rating on China Resources Pharmaceutical, Raises Target Price to HK$7.2

Stock News
·
Mar 27

CMSC International Raises CHINARES PHARMA (03320) Target Price to HK$6.3, Keeps "Add" Rating

Stock News
·
Mar 27

Stock Track | CHINARES PHARMA Soars 5.25% Intraday on Strong Earnings Results and Positive Outlook

Stock Track
·
Mar 27

CHINARES PHARMA Shares Extend Rally with Another 5% Gain

Stock News
·
Mar 27

CHINARES PHARMA Subsidiary Double-Crane Issues Up to RMB 1 Billion Corporate Bonds

Stock News
·
Mar 26

CR Pharma’s Subsidiary CR Double-Crane Issues RMB1.00 Billion Three-Year Bonds at 1.65% Coupon

Bulletin Express
·
Mar 26

CR Double-Crane issues 2026 corporate bonds; principal totals up to RMB1 billion at 1.65% coupon rate

Reuters
·
Mar 26

UBS Adjusts CHINARES PHARMA Target Price to HK$6.9, Citing In-Line Revenue and Above-Expectation Net Profit

Stock News
·
Mar 26

Stock Track | CHINARES PHARMA Soars 6.24% in Morning Session on Strong Annual Results with 20.73% Profit Jump

Stock Track
·
Mar 26

CHINARES PHARMA Shares Surge Over 6% in Morning Trading Following 20.73% Jump in Annual Net Profit

Deep News
·
Mar 26

BUZZ-China Resources Pharma hits more than 4-month peak on higher FY profit, dividend

Reuters
·
Mar 25

Stock Track | CHINARES PHARMA Soars 5.17% Intraday on Strong FY2025 Results That Beat Estimates

Stock Track
·
Mar 25

CHINARES PHARMA Reports Fiscal Year Profit Increase of 20.73% to 4.045 Billion Yuan

Stock News
·
Mar 25

China Resources Pharma proposes final dividend of RMB 0.122 per share

Reuters
·
Mar 25

China Resources Pharmaceutical - FY Profit Attributable RMB4.05 Bln

THOMSON REUTERS
·
Mar 25

China Resources Pharmaceutical Group - Final Dividend of RMB0.122 per Share

THOMSON REUTERS
·
Mar 25

China Resources Pharmaceutical FY2025 profit attributable to shareholders rose 20.7% to RMB4.05 billion

Reuters
·
Mar 25

CR Sanjiu 2025 net profit attributable to shareholders rises 1.58% to RMB3.42 billion

Reuters
·
Mar 20